An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions

Míreanna comhchosúla

• Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database
  de réir: Stefania Chiappini, et al.
  Foilsithe / Cruthaithe: (2020-02-01)
• Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.
  de réir: Onakpoya, I, et al.
  Foilsithe / Cruthaithe: (2016)
• The withdrawal of drugs from the market as a result of post-authorisation pharmacovigilance
  de réir: Łukasz Dobrek
  Foilsithe / Cruthaithe: (2022-08-01)
• Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
  de réir: Onakpoya, IJ, et al.
  Foilsithe / Cruthaithe: (2016)
• Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
  de réir: Igho J. Onakpoya, et al.
  Foilsithe / Cruthaithe: (2019-03-01)